Literature DB >> 20541569

Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization.

Kaleeckal G Harikumar1, Alicja M Ball, Patrick M Sexton, Laurence J Miller.   

Abstract

Dimerization of the prototypic family B G protein-coupled secretin receptor is determined by the lipid-exposed face of transmembrane segment four (TM4), and has substantial functional importance, facilitating G protein coupling. Recently, we demonstrated that the human secretin receptor elicits an inter-receptor bioluminescence resonance energy transfer (BRET) signal with most other human family B peptide receptors, except for the calcitonin receptor. In this study we have explored the occurrence and importance of calcitonin receptor oligomerization. Static and saturation receptor BRET were utilized to demonstrate that, unlike the human calcitonin receptor that does not yield a significant homomeric BRET signal, the rabbit calcitonin receptor exhibits strong resonance energy transfer. Within the lipid-exposed face of TM4, rabbit and human calcitonin receptors differ by a single amino acid (Arg236 in human; His in rabbit), while Thr253 that occurs in human and rabbit calcitonin receptors is unique across family B receptors. Mutating Arg236 or Thr253 of the human calcitonin receptor to residues found in the rabbit calcitonin receptor or the human secretin receptor (R236H, R236Y and T253A) resulted in generation of significant BRET signals. Similarly, mutation of Val250 of the human calcitonin receptor to another key lipid-facing residue found in the secretin receptor (V250I) also increased the receptor BRET signal. These data support the consistent theme of lipid-exposed residues of TM4 being important for the dimerization of the calcitonin receptor. However, rabbit and human calcitonin receptor constructs bound calcitonin and stimulated cAMP similarly, suggesting that differences in BRET could reflect differences in orientation or in the stability of homo-dimeric receptor complexes, which were nevertheless similarly effective in eliciting the functions attributed to that complex. The likelihood of human calcitonin receptor dimerization, even in the absence of a significant BRET signal, was further supported by data demonstrating that the peptide representing TM4 of this receptor that disrupts the rabbit receptor BRET signal, produced a right shift in the cAMP concentration-response curves for both rabbit and human receptors. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20541569      PMCID: PMC2926129          DOI: 10.1016/j.regpep.2010.06.001

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  35 in total

1.  Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation.

Authors:  Wen Guo; Lei Shi; Marta Filizola; Harel Weinstein; Jonathan A Javitch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

2.  Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function.

Authors:  Kaleeckal G Harikumar; Maoqing Dong; Zhijie Cheng; Delia I Pinon; Terry P Lybrand; Laurence J Miller
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

3.  Dimerization of corticotropin-releasing factor receptor type 1 is not coupled to ligand binding.

Authors:  Oliver Kraetke; Burkhard Wiesner; Jenny Eichhorst; Jens Furkert; Michael Bienert; Michael Beyermann
Journal:  J Recept Signal Transduct Res       Date:  2005       Impact factor: 2.092

4.  Transmembrane segment IV contributes a functionally important interface for oligomerization of the Class II G protein-coupled secretin receptor.

Authors:  Kaleeckal G Harikumar; Delia I Pinon; Laurence J Miller
Journal:  J Biol Chem       Date:  2007-08-28       Impact factor: 5.157

5.  How and why do GPCRs dimerize?

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Trends Pharmacol Sci       Date:  2008-04-01       Impact factor: 14.819

6.  Secretin receptor oligomers form intracellularly during maturation through receptor core domains.

Authors:  Cayle S Lisenbee; Laurence J Miller
Journal:  Biochemistry       Date:  2006-07-11       Impact factor: 3.162

7.  Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2).

Authors:  Ingrid Langer; Nathalie Gaspard; Patrick Robberecht
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

8.  Use of probes with fluorescence indicator distributed throughout the pharmacophore to examine the peptide agonist-binding environment of the family B G protein-coupled secretin receptor.

Authors:  Kaleeckal G Harikumar; Keiko Hosohata; Delia I Pinon; Laurence J Miller
Journal:  J Biol Chem       Date:  2005-11-30       Impact factor: 5.157

9.  Heterodimerization is required for the formation of a functional GABA(B) receptor.

Authors:  J H White; A Wise; M J Main; A Green; N J Fraser; G H Disney; A A Barnes; P Emson; S M Foord; F H Marshall
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

10.  Functional calcitonin gene-related peptide receptors are formed by the asymmetric assembly of a calcitonin receptor-like receptor homo-oligomer and a monomer of receptor activity-modifying protein-1.

Authors:  Madeleine Héroux; Mireille Hogue; Sébastien Lemieux; Michel Bouvier
Journal:  J Biol Chem       Date:  2007-09-04       Impact factor: 5.157

View more
  17 in total

Review 1.  The structure and function of the glucagon-like peptide-1 receptor and its ligands.

Authors:  Dan Donnelly
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  Emerging paradigms in GPCR allostery: implications for drug discovery.

Authors:  Denise Wootten; Arthur Christopoulos; Patrick M Sexton
Journal:  Nat Rev Drug Discov       Date:  2013-08       Impact factor: 84.694

Review 3.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 4.  Consequences of splice variation on Secretin family G protein-coupled receptor function.

Authors:  Sebastian G B Furness; Denise Wootten; Arthur Christopoulos; Patrick M Sexton
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 5.  Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25.

Authors:  Debbie L Hay; Michael L Garelja; David R Poyner; Christopher S Walker
Journal:  Br J Pharmacol       Date:  2017-11-28       Impact factor: 8.739

Review 6.  Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs?

Authors:  James Barwell; Joseph J Gingell; Harriet A Watkins; Julia K Archbold; David R Poyner; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

7.  A novel approach to quantify G-protein-coupled receptor dimerization equilibrium using bioluminescence resonance energy transfer.

Authors:  Irina Kufareva; Bryan Stephens; C Taylor Gilliland; Beili Wu; Gustavo Fenalti; Damon Hamel; Raymond C Stevens; Ruben Abagyan; Tracy M Handel
Journal:  Methods Mol Biol       Date:  2013

Review 8.  Ligand binding and activation of the secretin receptor, a prototypic family B G protein-coupled receptor.

Authors:  Laurence J Miller; Maoqing Dong; Kaleeckal G Harikumar
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

9.  Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery.

Authors:  Kaleeckal G Harikumar; Denise Wootten; Delia I Pinon; Cassandra Koole; Alicja M Ball; Sebastian G B Furness; Bim Graham; Maoqing Dong; Arthur Christopoulos; Laurence J Miller; Patrick M Sexton
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

Review 10.  Minireview: Signal bias, allosterism, and polymorphic variation at the GLP-1R: implications for drug discovery.

Authors:  Cassandra Koole; Emilia E Savage; Arthur Christopoulos; Laurence J Miller; Patrick M Sexton; Denise Wootten
Journal:  Mol Endocrinol       Date:  2013-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.